CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled
Drug / intervention
BMAC on PCL Scaffoldprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05241548
NCT05241548N/ACompleted

Bone Marrow Aspirate Concentrate(BMAC) on 3D Printed Polycaprolactone (PCL) Scaffold for Ridge Augmentation of Horizontal Alveolar Defects in Aesthetic Zone (Clinical Case Series Study)

Cairo University·interventional·Posted Feb 15, 2022·Updated Jan 21, 2026

In Brief

A clinical study evaluating BMAC on PCL Scaffold for Bone Loss in Jaw and Edentulous Alveolar Ridge. Completed, enrolled 7 participants across 1 site.

Detailed Summary

BMAC is used on 3D printed PCL scaffold for horizontal ridge augmentation in aesthetic zone , BMAC contains MSCs which can differentiate in osteogenic medium into osteoblasts which can lay down bone

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 15, 2022
Enrollment StartJan 15, 2022
Primary CompletionJun 1, 2023
Study CompletionDec 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 4.4 years ago

Interventions

BMAC on PCL Scaffoldprocedure

Horizontal ridge augmentation in aesthetic zone by using bone marrow aspirate concentrate on PCL scaffold